azatoxin has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bazylevich, A; Bovina, A; Firer, MA; Gellerman, G; Hesin, A; Kostenich, G; Luboshits, G; Oron-Herman, M; Ragozin, E; Rubinek, T; Shekhter Zahavi, T; Sherman, MY; Tuchinsky, H; Wolf, I | 1 |
1 other study(ies) available for azatoxin and Pancreatic Neoplasms
Article | Year |
---|---|
New somatostatin-drug conjugates for effective targeting pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Humans; Indoles; Kidney; Pancreatic Neoplasms; Peptides, Cyclic; Receptors, Somatostatin; Somatostatin; Stilbenes; Tissue Distribution; Xenograft Model Antitumor Assays | 2018 |